GL1X · GenesisL1 explorer

MolNFT v1 · #110301 · protein

The complex structure of C3CER exoenzyme and GTP bound rhoa (NADH-free state)

4XSG · Transforming protein rhoa: “The complex structure of C3CER exoenzyme and GTP bound rhoa (NADH-free state)”. X-ray diffraction, 2 ligands (GSP, MG), 5 pockets (best druggability 0.82). MolNFT v1 #110301 on GenesisL1: 3D structure…

PDB
4XSG
Type
protein
Length
381 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transforming protein rhoa; ADP-ribosyltransferase
UniProt
P61586, Q8KNY0
Ligands
GSP, MG
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransforming protein rhoaprotein17638% helix, 23% strandP61586
BADP-ribosyltransferaseprotein20531% helix, 29% strandQ8KNY0

Ligands and binding sites

  • GSP · 5'-guanosine-diphosphate-monothiophosphate · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17480.820.8665empty
23470.620.7844GSP, MG
3710.380.7821EDO
4580.340.7714empty
5620.290.7414empty

Interfaces

1 interface between chains.

  • A–B · 1432 Ų buried · 24 hydrogen bonds · protein-protein

Compared structures

  • 4XSG · The complex structure of C3cer exoenzyme and GTP bound RhoA (NADH-free state) · the same entry in another collection · chain A against A, TM-score 1.00
  • P61586 · AlphaFold monomer V2.0 prediction for transforming protein rhoa (P61586) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.